Drugs / Melatonin PR
last change Dec 2019 re-read 3 minutes ago

Melatonin PR

Developed for
REM sleep behavior disorder
Investigated by
Kuhnil Pharmaceutical Co., Ltd. · Seoul National University Hospital

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02789592 Jul 2016 → Dec 2019 Parkinson disease, REM sleep behavior disorder Seoul National University Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Melatonin PR ClinicalTrials.gov intervention name — accepted as the source's own label NCT02789592 ↗